Urol. praxi. 2025;26(3):165-168 | DOI: 10.36290/uro.2025.074

Chronic tubulointerstitial nephritis

MUDr. Petra Bachroňová, MUDr. Michal Sýkora, prof. MUDr. Ivan Rychlík, CSc., FASN, FERA, FISN
Interní klinika 3. LF UK a FNKV, Praha

Tubulointerstitial nephritis (TIN) represents a broad group of relatively heterogeneous diseases, characterized by predominant involvement of the tubules and interstitium. The pathophysiological process involves immune-mediated infiltration by inflammatory cells. When kidney cells are damaged, local antigens are expressed, leading to infiltration by inflammatory cells and activation of cytokines, which act both proinflammatory and as chemoattractant. Cytokine production by inflammatory cells (macrophages, lymphocytes) is also mediated by kidney cells (proximal tubular cells, vascular endothelial cells, interstitial cells, and fibroblasts), resulting in interstitial scarring, fibrosis, and tubular atrophy, ultimately leading to progressive chronic kidney disease. Chronic TIN can be etiologically divided into infectious, typically chronic bacterial pyelonephritis, and non-infectious, where the inflammatory process is triggered by medications, metabolic disorders, cystic diseases, autoimmune diseases or vesicoureteral reflux in childhood. Secondary involvement of the tubulointerstitium may also occur, for example, in vascular or ischemic kidney injury. The clinical presentation of chronic TIN is often nonspecific and rather oligosymptomatic, with milder mani­festations than in acute forms. It may present as various tubular dysfunctions or as progressive renal insufficiency. Treatment is targeted according to the primary cause.

Keywords: tubulointerstitium, nephritis, chronic tubulointerstitial nephritis.

Accepted: September 29, 2025; Published: October 17, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bachroňová P, Sýkora M, Rychlík FISN I. Chronic tubulointerstitial nephritis. Urol. praxi. 2025;26(3):165-168. doi: 10.36290/uro.2025.074.
Download citation

References

  1. Bachroňová P, Rychlík I. Tubulointersticiální nefritidy a infekce močových cest. In: Rychlík I, Widimský P (Eds). Vnitřní lékařství, II. díl (pro studenty a lékaře ve společném interním kmeni). Praha: Maxdorf; 2024, ISBN 978-80-7345-781-5, s. 154-163.
  2. Paříková A. Tubulointersticiální onemocnění. In: Tesař V, Viklický O (Eds). Klinická nefrologie. 2., zcela přepracované a doplněné vydání. Praha: Grada Publishing; 2015. ISBN: 978-80-247-4367-7, s.289-303.
  3. Perazella MA. Clinical Approach to Diagnosing Acute and Chronic Tubulointerstitial Disease. Adv Chronic Kidney Dis. 2017;24:57-63. Go to original source... Go to PubMed...
  4. Horáčková M. Tubulointersticiální nefritidy/tubulointersticiální nefropatie. Aktuality v nefrologii. 2024;30:51-58.
  5. Horáčková M. Analgetika a ledviny: vztah hodnocený klinickým nefrologem. Praha: Triton; 2000. ISBN: 978-80-7254-149-2, 165 s.
  6. Mallawaarachchi AC, Fowles L, Wardrop L, et al. Genomic Testing in Patients with Kidney Failure of an Unknown Cause. A National Australian Study. CJASN 2024;19:887-897. Go to original source... Go to PubMed...
  7. Jadot I, Declèves AE, Nortier J, et al. An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature. Int. J Mol Sci. 2017;18:297; https://doi.org/10.3390/ijms18020297. Go to original source... Go to PubMed...
  8. Cortinovis M, Perico N, Remuzzi G. Tubulointerstitial injury in proteinuric chronic kidney diseases. Front Med Sec. 2024;11:1478697. https://doi.org/10.3389/fmed.­2024. 1478697. Go to original source...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.